Observational data from 31 cases of stage III colorectal adenocarcinomas reveal significant but inconsistent MMP9 expression across different tumor cells, with higher levels in poorly and moderately differentiated carcinomas compared to well-differentiated ones. The gene discussed is MMP9; the disease is neoplasm.